SANFORD HILLSBORO — History
CCN 351329 | 3-year financial timeline | COVID resilience: 81/100
🛡️ Public data only — no PHI permitted on this instance.
$15M
Latest Revenue (FY2022)
+10.6%
Revenue CAGR (3yr)
2.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $13M | $14M | $15M | +8.3% | +10.6% |
| Operating Expenses | $14M | $16M | $15M | -3.3% | +3.1% |
| Operating Margin | -12.6% | -9.6% | 2.2% | +123.4% | +0.0% |
| Net Income | $-2M | $-1M | $0M | +125.3% | +0.0% |
| Licensed Beds | 16 | 16 | 16 | +0.0% | +0.0% |
| Total Patient Days | 2,455 | 2,353 | 2,266 | -3.7% | -3.9% |
| Medicare Day % | 39% | 65% | 49% | -24.4% | +12.6% |
| Medicaid Day % | 34% | 15% | 19% | +28.4% | -26.0% |
COVID Impact & Recovery
Resilience Score: 81/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +22.4% ($13M → $15M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+10.6%
This Hospital
+7.6%
State Avg
Latest Margin
2.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $17M | 9.7% |
| FY2024 (proj) | $18M | 17.1% |
| FY2025 (proj) | $20M | 24.5% |